Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$960K Buy
10,098
+2,030
+25% +$249K ﹤0.01% 2597
2025
Q4
$1.33M Sell
8,068
-1,312
-14% -$174K ﹤0.01% 2472
2025
Q3
$969K Buy
9,380
+1,714
+22% +$168K ﹤0.01% 2640
2025
Q2
$954K Buy
+7,666
New +$990K ﹤0.01% 2626
2023
Q2
Sell
-9,742
Closed -$1.48M 3262
2023
Q1
$1.48M Sell
9,742
-141
-1% -$28.6K ﹤0.01% 2461
2022
Q4
$2.82M Buy
9,883
+9,052
+1,089% +$1.74M ﹤0.01% 2231
2022
Q3
$187K Hold
831
﹤0.01% 3117
2022
Q2
$402K Buy
+831
New +$980K ﹤0.01% 3062

Other funds holding NUTX

Nuveen's NUTX Position: Q1 2026 in Review

Nuveen increased its Nutex Health (NUTX) stake by 25% in Q1 2026, buying an estimated $249K and bringing the position to 10,098 shares worth $960K. The position accounts for ﹤0.01% of the portfolio, ranked #2597.

Nuveen first reported a position in NUTX in Q2 2022 and has held it in 8 quarters since. The position peaked at $2.82M in Q4 2022. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • Nuveen held 10,098 shares of Nutex Health worth $960K as of Q1 2026.
  • Nuveen bought 2,030 Nutex Health shares in Q1 2026, an estimated $249K.
  • Nutex Health made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2597 holding.
  • Nuveen first reported a position in Nutex Health in Q2 2022 and has held it in 8 quarters since.
  • Nuveen's Nutex Health position peaked at $2.82M in Q4 2022.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.